Response to: 'Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients' by Humby et al

Buch, MH orcid.org/0000-0002-8962-5642, Melville, A and McGonagle, DG (2020) Response to: 'Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients' by Humby et al. Annals of the rheumatic diseases, 79 (11). e140. ISSN 0003-4967

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. This manuscript version is made available under the CC BY-NC 4.0 license https://creativecommons.org/licenses/by-nc/4.0/
Keywords: dmards (biologic); dmards (synthetic); early rheumatoid arthritis; fibroblasts; osteoarthritis
Dates:
  • Accepted: 17 June 2019
  • Published (online): 13 July 2019
  • Published: 12 October 2020
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Clinical Musculoskeletal Medicine (LIRMM) (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Experimental Musculoskeletal Medicine (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 05 Aug 2019 10:32
Last Modified: 21 Dec 2020 23:05
Status: Published
Publisher: BMJ Publishing Group
Identification Number: 10.1136/annrheumdis-2019-215881
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics


CORE (COnnecting REpositories)